Collectively, our findings suggested a potential protective role for Ism1 against obesity and its complications, indicating it as a potential biomarker or diagnostic tool for early detection of metabolic diseases, warranting further investigation into its therapeutic potential. Here, ISM1 is linked to Other metabolic disease.